申请人:The Board of Regents of the University of Oklahoma
公开号:US11203582B2
公开(公告)日:2021-12-21
Novel 3-(N-piperidinyl)methyl benzamide derivatives are disclosed. The compounds can be used in treating diseases and conditions which are associated with abnormal cell function related to endoplasmic reticulum (ER) stress. For example, the compounds can be used as suppressors of ER stress-induced pancreatic β-cell dysfunction and death, for example in the treatment of diabetes.
新型3-(N-哌啶基)甲基苯甲酰胺衍生物被披露。这些化合物可用于治疗与内质网(ER)应激相关的异常细胞功能相关的疾病和病症。例如,这些化合物可作为ER应激诱导的胰腺β细胞功能障碍和死亡的抑制剂,例如在治疗糖尿病中使用。